Shanghai Serum Bio-Technology Co., Ltd.

688163

CNE1000059X8

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 20/06/2024 BST			5-day change	1st Jan Change
12.54 ^CNY	-1.26%		+0.48%	-37.27%

04-26	Shanghai Serum Bio-Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-23	Shanghai Serum Bio-Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shanghai Serum Bio-Technology Co., Ltd.(SHSE:688163) added to Shanghai Stock Exchange Composite Index

March 13, 2023 at 04:00 am

Shanghai Serum Bio-Technology Co., Ltd Added to Shanghai Stock Exchange Composite Index.

Latest news about Shanghai Serum Bio-Technology Co., Ltd.

Shanghai Serum Bio-Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Shanghai Serum Bio-Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Shanghai Serum Bio-Technology Gets Nod from Research Institution for Phase II of Anti-Viper Venom Injection Trial	01-17	MT
Shanghai Serum Bio-Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Serum Bio-Technology's Chairman Detained	31/07/23	MT
Shanghai Serum Bio-Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	20/04/23	CI
Shanghai Serum Bio-Technology Co., Ltd.(SHSE:688163) added to Shanghai Stock Exchange Composite Index	13/03/23	CI
Shanghai Serum Bio-Technology Co., Ltd.(SHSE:688163) added to Shanghai Stock Exchange A Share Index	13/03/23	CI
Shanghai Serum Bio-Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
Shanghai Serum Bio-Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22	CI
Shanghai Serum Bio-Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22	CI
Shanghai Serum Bio-Technology Co., Ltd. has completed an IPO in the amount of CNY 893.7918 million.	04/03/22	CI
Shanghai Serum Bio-Technology Co., Ltd. has filed an IPO.	19/12/21	CI

Chart Shanghai Serum Bio-Technology Co., Ltd.

Duration

Period

Chart Shanghai Serum Bio-Technology Co., Ltd.

More charts

Shanghai Serum Bio-Technology Co Ltd is a China-based company mainly engaged in the research and development of antisera and antitoxins. The Company is mainly engaged in the research, development, manufacturing and sales of preventive and therapeutic drugs in the field of biotoxins and biosafety. The Company's main products include anti-pit viper venom, anti-five-step snake venom, anti-bungi venom, anti-cobra venom, equine immunoglobulin and anti-rabies serum. The Company's products are mainly used for emergency snakebite treatment. The Company mainly conducts its businesses in the domestic market.

Sector

Pharmaceuticals

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD.	-37.27%	189M
CSL LIMITED	+2.22%	93.53B
SAMSUNG BIOLOGICS CO.,LTD.	-1.32%	38.27B
BIOGEN INC.	-13.44%	32.84B
UCB	+76.30%	27.83B
BIOMARIN PHARMACEUTICAL INC.	-13.11%	16.08B
INCYTE CORPORATION	+0.68%	14.02B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.06%	11.47B
ALTEOGEN INC.	+185.28%	9.92B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-53.00%	9.42B